Stock Market Update - February 12, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. MGRT - Mega Fortune Company Limited
Price: $12.34 | Change: +112.39% ($6.53)
MGRT recently made headlines with a staggering 112.39% gain. This dramatic price surge was driven by heavy buying interest and a significant spike in trading volume, leading to rapid movements that even triggered multiple automatic trading pauses. Bullish technical indicators also attracted momentum traders.
What's particularly interesting about MGRT's impressive climb is the lack of a clear fundamental catalyst. There were no specific company news, earnings reports, or product launches announced to explain such a drastic jump. Instead, the stock's movement appears to be primarily fueled by market sentiment and speculative trading, rather than concrete corporate developments.
2. BANXR - ArrowMark Financial Corp.
Price: $0.06 | Change: +81.82% ($0.027)
BANXR just rocketed up 81.82%, and the story behind this surge is all about a unique event: a transferable rights offering. ArrowMark Financial Corp. initiated this offering to raise additional funds for investment, providing existing shareholders with a special opportunity.
Shareholders received "rights" (traded under the symbol BANXR) allowing them to subscribe for new common shares at a potentially discounted rate. With the deadline to exercise these rights on February 18, 2026, quickly approaching, demand for BANXR has notably increased. Investors are actively purchasing these rights, either to acquire the underlying BANX common stock at a favorable price or for speculative purposes before they expire.
This late-stage rush to acquire rights is the likely catalyst for BANXR's recent upward move. The company plans to use the new capital to enhance its investment portfolio, particularly in securities anticipated to yield steady income distributions.
3. FSLY - Fastly, Inc.
Price: $16.04 | Change: +72.29% ($6.73)
FSLY:NASDAQ recently saw an impressive 72.29% gain! This significant surge followed the company's release of exceptional fourth-quarter and full-year 2025 financial results, alongside a very optimistic outlook for 2026. Fastly reported record Q4 revenue of $172.6 million, exceeding analyst estimates, and achieved its first-ever profitable fiscal year in 2025.
What truly propelled the stock was Fastly's strong 2026 guidance, projecting full-year revenue well above analyst consensus. CEO Kip Compton emphasized that "agentic AI" is becoming a substantial tailwind for the business, with Fastly's edge cloud platform uniquely positioned to optimize and secure these evolving AI systems. This combination of robust performance and promising future trends led to increased investor confidence and analyst upgrades.
4. GLTO - Galecto, Inc.
Price: $30.03 | Change: +37.75% ($8.23)
GLTO experienced a notable 37.75% gain following the successful closing of its underwritten public offering around February 13, 2026. Galecto, Inc. raised approximately $316.3 million in gross proceeds by selling over 16.6 million shares at $19.00 each.
This significant capital infusion is a crucial boost for the biotech firm. The funds are earmarked to finance operations into Phase 3 development of their lead candidate, DMR-001, which targets blood cancer treatments. The money will also support preclinical studies, clinical trials, and other research and development activities.
The market views this successful financing round as a strong positive catalyst. It directly enables Galecto to advance its key pipeline assets, signaling investor confidence in the company's ability to progress its crucial drug development efforts.
5. CGNX - Cognex Corporation
Price: $58.67 | Change: +36.35% ($15.64)
CGNX saw an impressive 36.35% jump in its stock price recently. This surge for Cognex Corporation came after the company reported strong fourth-quarter 2025 financial results and painted an optimistic picture for the future. They announced Q4 revenue of $252 million, a 10% year-over-year increase, and adjusted earnings per share jumped 35% to $0.27, both exceeding what analysts expected.
A significant factor was the expansion of Cognex's adjusted EBITDA margin, which hit 22.7% in Q4 2025—marking six straight quarters of improvement. The company also gave strong guidance for the first quarter of 2026 and outlined ambitious long-term growth and profitability targets, fueled by strategic moves in AI-enabled machine vision. This positive financial momentum and forward-looking strategy led analysts to upgrade their views and drove the substantial stock surge.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.